Leading Life Science Innovation
Discover the future of omics with MGI's Next-Generation Sequencing: ultra-high throughput, scalability, and speed. Enhance your research with precision sequencing, advanced automation, and integrated bioinformatics, expanding the possibilities in genomics.
Leading with innovation to all Sequencing Industry Explorers
Sequencing platforms
Maximize your sequencing projects with DNBSEQ™, delivering superior accuracy and efficiency for all genomic research.
Laboratory automation
Our scalable lab automation systems ensure adaptability, supporting applications from diagnostics to genomics.
Bioinformatics software
Advanced tools and sequencing technologies drive insights into genetics, empowering multiomics breakthroughs.
Novel Products
Unlock precision with DNBSEQ™ chemistry, NGS, Stereo-Seq, and Single-cell platforms for seamless integration in genetic studies.
Employees Worldwide, including 33.4% in R&D, with 9 R&D centers, 7 production centers, and 10+ CEC labs.
Papers published in top scientific journals, including 900+ in CNS, Lancet, and other core journals based on the DNBSEQ platform.
In the science journal
Comprehensive Tumor Profiling Using NGS: Precision Oncology, Liquid Biopsy and Clinical Decision Support
comprehensive tumor profiling
Mar 6, 2026
Advances in next-generation sequencing (NGS) are transforming precision oncology by enabling comprehensive tumor profiling, liquid biopsy analysis, and data-driven clinical decisions, supporting faster diagnostics and more personalized cancer treatment.
